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ABSTRACT 
Background: Sex differences in rates of depression emerge during adolescence. However, it is unclear 
whether symptom patterns and trajectories differ significantly according to gender in youth. Barriers to 
research include the fact that most self-report tools are weighted towards psychological rather than 
somatic symptoms.  
 
Methods: Data were collected on symptoms of depression in about 1800 individuals at ages 12, 14 and 
16 years. Odds ratios and 95% confidence intervals were used to examine the trajectory of psychological 
and somatic phenotypes and self-reported depression caseness over time. 
 
Results: At age 12, 24% of participants met criteria for self-reported depression caseness. Although 
there was only a small incremental increase in the prevalence over time (about 5%), 57% of participants 
met criteria for self-reported depression caseness at least once. Generic symptoms at age 12 were 
associated with depression longitudinally, although early transition to caseness was reported in females 
only. Categorization as a psychological phenotype at age 12 predicted depression at age 14 and/or 16 
years, especially in females. The somatic phenotype was more common in males, but showed a weaker 
association with self-reported depression caseness over time.  
 
Limitations: Depression was assessed by self-report; only 30% of participants had ratings for age 12, 14 
and 16. 
 
Conclusions: Although sub-threshold psychological and somatic syndromes often co-occur in cases of 
self-reported depression in adolescence, longitudinally they may represent independent symptom 
trajectories. However, it is important to remember that self-reported depression is indicative of, but not 
confirmation of a depressive episode that meets diagnostic criteria. 
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INTRODUCTION 
A recent systematic review by Musliner et al (2016) identified that trajectories of depressive symptoms in 
the general population are heterogeneous and that symptom patterns may vary in terms of severity (low, 
medium, and high) and stability (stable, increasing, and decreasing). The review confirmed that female 
gender, peer relationships and socio-economic status were associated with patterns of depression, and it 
was noted that over time: (i) stability of depressive symptoms was more common than instability; (ii) 
most individuals reported no depressive symptoms or minimal symptoms; and (iii) chronic mild-
moderate level symptoms can be quite common, but chronic severe depressive symptoms were rare. 
The review is one of the first to offer insights regarding trajectories and symptom patterns. However, 
it did not explore whether particular types of symptoms or sub-threshold phenotypes were more 
likely to be associated with depression caseness at follow-up. Another potential limitation was that 
less than a third of the eligible studies examined samples of children or adolescents (7 of 25 studies) 
and those that were included all came from North America (USA=5; Canada=2). Given that 
depression is ranked worldwide as the most burdensome condition in individuals aged less than 25 
years (Gore et al, 2011), we decided to examine trajectories of self-reported depression in a community-
based cohort of adolescents recruited to a long-term study in Australia. 
 
The importance of identifying depression and understanding its trajectories in adolescents cannot be 
overstated as depression onsets prior to the age of 17 years are associated with increased risk of adult 
mental disorders, reduced response to standard therapeutic strategies as adults, adverse social and 
clinical outcomes, high levels of morbidity and all-cause mortality (Zisook et al, 2007; Substance Abuse 
and Mental Health Services Administration [SAMHSA], 2014). Furthermore, Carrellas et al (2017) 
demonstrated that sub-threshold syndromes are also associated with significant morbidity and social 
impairment. Longitudinal cohort studies identify that rates of depression are higher in females as 
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compared to males (e.g. Essau et al, 2010; Patton et al, 2014), that the sex differences become most 
apparent post-puberty and that these differences are a consequence of both a higher risk of incident 
cases and a higher prevalence of recurrent or chronic depressions. However, there is limited 
information about the prevalence of sub-threshold risk syndromes for depression caseness in this age 
group (e.g. Dekker et al, 2007).  
One of the significant barriers to exploring clinical phenotypes associated with depression in youth 
relates to the nature of the assessment instruments employed (Angold et al, 2002; Cole et al, 2011). The 
burden on young study participants means that there is reluctance to employ the extensive structured 
assessments used with adults. There is evidence that alternative tools can be valid and that self-report 
diagnosis has been previously reported as an adequate proxy measure for clinician diagnosis of 
depression, when compared to the Structured Clinical Interview for DSM-IV (Sanchez-Villegas et al., 
2008). However, the potential issue in using some of the most widely employed screening tools for 
depression is that they may introduce unexpected biases in case identification according to sex. For 
example, two of the most widely used assessments for depression (and other common mental disorders 
in adolescents), the Short Mood and Feelings Questionnaire and the Strengths and Difficulties 
Questionnaire, are weighted towards the psychological and cognitive-emotional features rather than 
somatic symptoms (Kent et al, 1997). This might lead to an under-estimation of the risk of depression 
in young males and some (but not all) studies of depressive symptoms in adolescents suggest that, 
compared to females, depressed males may self-report more morning fatigue, anhedonia or somatic 
symptoms and that these may be precursors to, or symptoms of depressive episodes (e.g. van Beck et al, 
2012).  Overall, prospective observation of somatic and psychological profiles separately and together 
could shed light on variations in illness trajectories according to these sub-threshold phenotypes, gender 
and the stability or severity of depressive symptoms over time. 
 
This report from the Brisbane Longitudinal Twin Study (BLTS) describes the use of an established 12-
item self-rating scale, called the Somatic and Psychological HEalth REport (SPHERE-12; Hickie et al, 
2001), to: 
(a) determine the proportion of males and females who meet SPHERE-12 criteria for psychological or 
somatic phenotypes or self-rated depression caseness at ages 12, 14 and 16 years, and  
(b) evaluate trajectories of self-reported depression in terms of severity and stability over time.  
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METHODS 
Sample 
The population sample was derived from >1800 adolescent and young adults who were all participating 
in three linked BLTS studies; the same recruitment and assessment procedures were used for 
identifying and following the cohort (for details see online material, Appendix 1). Ethical approval was 
obtained from the Human Research Ethics Committee at the Queensland Institute of Medical Research 
for all BTLS research projects, and written informed consent was obtained from a parent or guardian 
for all individuals aged less than 18 years.  
 
A detailed description of the study protocol and procedures, recruitment strategies and populations 
included in the BLTS is given elsewhere (Wright & Martin, 2004). The present study included those 
individuals with data available on basic demographic information who participated in prospective 
monitoring and completed at least two SPHERE-12 self-assessments (as we wished to examine the inter-
relationships between different symptom profiles and trajectories in the same individual over time). 
Individuals eligible for inclusion comprised of three sub-samples: 600 individuals with SPHERE-12 self-
assessments at three specified time points (ages 12,14, and 16); 714 individuals with self-assessments at 
ages 12 and 16, and 750 with self-assessments at ages 14 and 16.  
 
Measures 
a) Demographics: Sex and age at each assessment were recorded. 
 
b) Symptom ratings: We used the SPHERE-12 to obtain ratings of generic symptoms, somatic and 
psychological sub-types and of self-reported depression caseness (identified by a pre-specified 
combination of somatic and psychological symptoms) at ages 12, 14 and 16.  
 
The SPHERE was originally designed for use in community, primary care and general medical settings 
where somatic symptoms (such as fatigue) often overlap with psychological complaints of depression 
and anxiety (Hickie et al, 2001; McFarlane et al, 2008). For the12-item version of the SPHERE, 
participants indicate if they had been troubled by symptoms over the past few weeks (e.g. psychological 
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items include: Feeling unhappy and depressed, Everything getting on top of you; whilst somatic 
items include: Prolonged tiredness after activity, Waking up tired), and individuals are required to 
make one of three response choices to each item: 0= “never or some of the time”; 1= “a good part of 
the time”; or, 2= “most of the time”. Item ratings were summed to obtain scores on two subscales (each 
consisting of six items) that best describe the likely presence of somatic symptoms such as fatigue 
(‘SOMA’) or of common symptoms of depression and anxiety (‘PSYCH’); simultaneous high scores on 
both scales are an indicator of likely depression caseness. The total score on the SPHERE-12 can be 
used as a continuous measure of symptoms, but usually the SPHERE subscale scores are used to create 
(i) two broadly defined or self-rated sub-threshold presentations: PSYCH (PSYCH score>=2 and 
SOMA<3) or SOMA (SOMA>=3 and PSYCH<2), and (ii) narrowly defined self-rated depression 
caseness (PSYCH score>=2 and SOMA>=3). 
 
The scale has high internal consistency (PSYCH .9; SOMA .8) and test-retest reliability (PSYCH .81; 
SOMA .8) (Hickie et al, 2001). In a study of over 800 young adults, McFarlane et al (2008) noted that 
the PSYCH scale compared favorably with the Hospital Anxiety and Depression Scale (.67-.73) and that 
the Receiver Operating Curve (ROC) for the PSYCH was .73 and for the SOMA was .72. As expected 
the subthreshold and threshold caseness ratings show contrasting sensitivity and specificity profiles, with 
the PSYCH and SOMA cutoffs having high levels of sensitivity (93%), whilst the more narrowly defined 
depression caseness has a higher level of specificity (72%).  In a sub-sample of cases, we confirmed a 
similar adequate level accuracy of the SPHERE-12 for identifying cases of major depression in this 
study (see online material, Appendix 2). 
 
Definitions of trajectories  
Ratings on the SPHERE-12 were used to evaluate self-reported trajectories of depressive symptoms 
using Musliner et al’s (2016) approach that focused on severity (low, medium, high) and stability (stable, 
increasing, decreasing):  
a) Severity: the lowest level of severity was defined by the total score on the SPHERE-12 at 
baseline assessment (analysed as a continuous measure).  Medium severity was defined by a 
score above the cut-off for either the PSYCH or SOMA sub-threshold phenotype at any time 
point. A high level of severity was defined as meeting SPHERE-12 criteria for depression 
caseness at any time point.  
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b) Stability: we assessed fluctuations in ‘caseness’ (PSYCH, SOMA or depression) over the study 
period. A stable trajectory indicated that SPHERE-12 self-ratings did not change over time. 
Trajectories were defined as unstable if the SPHERE-12 ratings fluctuated between assessment 
points, with an increasing trajectory identified by a change from self-rated sub-threshold 
phenotypes to depression caseness and a decreasing trajectory identified by a change from self-
rated depression caseness to subthreshold phenotypes. 
 
Statistical analysis 
All statistical analyses utilized the Statistical Package for the Social Sciences version 22 (SPSS, Chicago, 
USA). As the subgroups included in each analysis included variable proportions of twins and non-twin 
siblings, all cases were considered as singletons. 
 
Prior to undertaking the main analyses, we examined whether the sub-samples included in different 
analyses were representative of the total sample. We used chi-squared tests to compare each selected 
sub-sample with the original larger samples of the same age group and evaluated the prevalence and 
gender distributions of subthreshold syndromes (PSYCH or SOMA) and depression caseness (i.e. the 
age 12 sub-sample of included cases vs. all age12 data, etc.). The analyses demonstrated that individuals 
included in this study are representative of the BLTS population from which they were selected (for 
details see Table S1 in the online supplementary material).  
 
The main analyses proceeded in several pre-defined steps: 
1) Prevalence by age and gender: We calculated prevalence of different levels of caseness (non-
case; PSYCH, SOMA, or depression case) at ages 12, 14 and 16 for males and females and 
report adjusted odds ratios (AOR) and 95% confidence intervals (CI) for the comparison of 
rates by sex.  
2) Baseline ratings versus outcomes at 14 and 16 years: we explored whether symptom ratings 
obtained at age12 predicted outcomes at each follow-up. First, we analysed any changes from 
the lowest level of severity at age 12 (generic SPHERE symptoms) to the highest level of severity 
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(depression caseness) at age 14 or 16. The OR and AOR indicate the likelihood and speed of 
transition and any gender differences. Second, we calculated the odds that individuals meeting 
criteria for moderate severity (PSYCH or SOMA subtype) or high severity (self-reported case of 
depression) at age 12 or at 14 years would be classified as a self-rated depression case at age 16.  
3) In the sub-sample of 600 cases with ratings at each time point, we examined individual 
trajectories over time and estimated the number of different patterns of sub-threshold and 
threshold syndromes and report the prevalence for each different trajectory for self-reported 
depression caseness. Odds ratios and AOR were calculated to determine whether meeting 
criteria for a PSYCH or SOMA phenotype was associated with a a course characterized by 
mostly being a depression case or ostly a non-case.  
 
RESULTS 
As shown in Table 1, 24% of the total cohort had already reached our threshold for self-rated 
depression caseness by age 12, rising to 30% by age 16, with most of the increase being accounted for by 
a bigger rise in the number of female (24% to 33%) compared to male cases (23% to 26%). 
Subthreshold syndromes showed slightly different patterns, with the number of SOMA only cases 
increasing in males between ages 12 and 14 (16% to 28%), and then stabilizing. The prevalence of 
PSYCH only cases showed relative stability over time, although rates were higher in females aged 14 
and 16.  
 
Table 1 about here 
 
The AOR reported in Table 1 highlight that cross-sectional analysis of rates of self-rated subthreshold 
and threshold levels of caseness demonstrated no sex differences at age 12, but a significantly greater 
likelihood for both self-rated depression and PSYCH caseness in females compared to males at ages 14 
and 16. In contrast, SOMA only caseness was significantly more common in males compared to 
females at ages 14 and 16. 
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Next, we examined any associations between different levels of severity at baseline assessment and 
future outcomes. Using the SPHERE-12 symptom score at 12 years (sample mean=3.26; standard 
deviation=2.84), we examined whether the overall level of generic depressive symptoms predicted future 
depression caseness. It was found that the odds for transition to the highest level (self-rated depression 
caseness) at follow-up was only significant for females at age 14 (AOR=1.86; 95% CI: 1.26, 2.75), but 
was significant for both males and females at age 16 (OR=1.22; 95% CI: (1.14, 1.29).  
 
Table 2 about here 
 
We then examined whether moderate or high severity at age 12 or 14 was associated with outcome at 
age 16 years. As shown in Table 2, longitudinal analyses demonstrated that the odds of being a self-rated 
depression case at age 16 were increased in individuals (and especially in females) who met criteria for 
PSYCH only caseness at ages 12 or 14. However, SOMA only caseness at age 12 or 14 did not predict 
self-rated depression caseness at age 16. Likewise, there were sex differences in changes from 
depression caseness at age 12 to sub-threshold syndromes (i.e. PSYCH only or SOMA only) at age 14 
or 16. Females who met criteria for self-rated depression caseness at age 12 were significantly more 
likely than males to meet criteria for PSYCH caseness at age 14 (AOR=1.75; 95% CI: 1.21, 2.95) and 
16 (AOR=2.32; 95% CI: 1.19, 2.64). However, males were significantly more likely to be a SOMA case 
at age 16 compared to females (AOR=.58; 95% CI: 0.38, 0.87). 
 
Table 3 about here 
 
 
Figure 1 about here 
 
Figure 1 provides a schematic representation of self-rated depression caseness in the 600 individuals 
assessed at three consecutive time points. The diagram demonstrates that, although there is only a five 
percent incremental increase in the proportion of the total subsample who met criteria for self-rated 
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depression caseness at age 12 and16 (a shift from 23% to 28%), individual trajectories could be classified 
on one of eight different pathways. Over the four-year observation period, 57% of the cohort was 
classified as a self-rated depression case on at least one occasion. As shown, the two most stable 
trajectories (no change over time) comprised of 43% of the sample (258 individuals) who never met 
criteria for self-rated depression caseness (category ‘NNN’), and one percent (8 individuals) who met 
criteria for self-rated depression caseness at every time point (category ‘CCC’). Between 4% and 17% of 
the sample followed each of the other trajectories (see Figure 1). We estimated that the odds were low 
(OR 0.49 95% CI: 0.34, 0.72) that individuals who met criteria for any level of caseness (PSYCH, 
SOMA, self-rated depression) at age 12 would never be a case at follow-up (i.e. would be classified as 
‘mostly a non-case’ or a ‘consecutive non-case’). In contrast, threshold or sub-threshold caseness at age 
12 was significantly associated with an increased likelihood of self-rated depression caseness on two or 
more occasions during the four-year follow-up period (OR 1.91; 95% CI 1.31, 4.29).  
 
 
DISCUSSION 
This study identified that about a quarter of young people completing the SPHERE-12 met criteria for 
self-rated depression caseness at age 12, and that self-rated caseness increased to nearly a third by age 
16, with a greater rise in young females compared to males. These findings are in keeping with previous 
longitudinal studies that re-assess youth throughout adolescence and suggest that depression, however 
defined, increases significantly from puberty up to age 16, especially in females (Essau et al, 2010; 
Costello et al, 2011; Patton et al, 2014). Several of these prospective studies have addressed transitions 
to self- or observer-rated depression caseness in individuals presenting with lower levels of depression 
severity (e.g. Kim-Cohen et al, 2003; Dekker et al, 2007; Hill et al, 2014). However, as demonstrated by 
Musliner et al (2016), fewer studies have examined individual trajectories of self-rated depression in 
terms of levels of severity or stability over time. Furthermore, it is unclear whether sub-threshold 
phenotypes are more strongly associated with different self-rated outcomes in males and females (e.g. 
McLeod et al, 2016; Salk et al, 2016). As such our paper is an important addition to the existing 
literature. 
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There are three key findings in the present study. First, although the absolute increase in prevalence of 
self-rated depression was modest (a change of about 5% over four years), this result masked significant 
variations in the self-rated pathways to caseness by age 16. As suggested by Musliner and colleagues 
(2016), the most common pattern was a stable state of minimal or no symptoms (in our study, 43% were 
stable non-cases), but it was notable that other individuals showed variable trajectories. Overall, 57% of 
individuals met our criteria for the most severe level of depression (self-reported caseness) at least once 
during the follow-up period. Second, our lowest level of severity, namely non-specific symptom load, 
identified that females with a higher number of generic SPHERE-12 symptoms at age 12 were likely to 
make an earlier transition to self-rated depression caseness (by age 14) than males. Third, we report 
novel findings in relation to our medium level of severity (self-rated subthreshold PSYCH or SOMA 
clinical phenotypes), with our results offering provisional support for the notion that there may be 
different types of symptom pathways experienced during the critical period of 12-16 years. In one 
pathway, a sub-threshold PSYCH syndrome may predate or follow-on from self-rated depressive 
caseness. This is consistent with the hypothesis that these phenotypic expressions are intrinsically-
linked, more typically seen in females rather than males and represent common experiences of 
symptoms of depression and anxiety (Simms et al, 2012). In contrast, the sub-threshold SOMA 
syndrome behaves largely independently, being significantly associated with male sex and relatively 
stable over time. 
 
In previous BLTS publications, such as Hickie and Rodgers (2011), it was hypothesized that the sub-
threshold PSYCH syndrome represents a common anxiety-depression diathesis underpinned by 
different neurobiological phenomena (e.g. high arousal, excessive sympathetic nervous system reactivity) 
than the sub-threshold SOMA syndrome, which may represent a (hypo)mania-fatigue dimension 
(possibly linked neurobiologically to circadian rhythm disturbance). Hansell et al (2012) have also 
demonstrated modest but significant heritability (h
2
) for SPHERE psychological symptoms (h
2
=0.38) and 
somatic symptoms (h
2
=0.43). Future follow-ups of the cohort will address these issues in detail and 
establish whether the PSYCH and SOMA phenotypes delineate different trajectories such as observer-
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rated recurrent depression, bipolarity or other heterotypic outcomes (Hickie et al, 2013; Scott et al, 
2016). As the putative genetic and environmental risks underpinning the observed sex differences in 
changes in psychological and somatic symptoms, are still not well understood (e.g. Fowler et al, 2006); 
more exhaustive, genetically informative longitudinal designs will enable us to model any observed 
changes over time (Hickie et al, 1999; Gillespie et al, 2000).  
 
There are several limitations to the study. First, as highlighted, although about 1800 individuals 
completed at least one SPHERE assessment, which allowed cross-sectional comparison of self-rated 
depression and subthreshold syndromes by sex at each time point, only about 30% of study participants 
completed three consecutive assessments over four years. However, we are encouraged that there were 
no significant differences in the clinical characteristics of the individuals who were included or excluded 
from the trajectory analysis. Second, whilst the SPHERE questionnaire can be used to screen for 
depression caseness, the psychological and somatic items were originally selected to also detect anxiety 
and fatigue symptoms, so it is not purely a screen for depression, but also for other common mental 
disorders such anxiety, etc. (Hickie et al, 2001; McFarlane et al, 2008). Third, and most important, we 
were not able to combine findings of SPHERE self-ratings with data from structured assessment 
interviews at each time point. As noted in this paper (see methods and Appendix 2), the overall the 
accuracy of the SPHERE (compared to the Composite International Diagnostic Interview) was about 
60%. Further, whilst we can report that the prevalence of self-rated depression caseness exceeded that of 
major depression caseness diagnosed according to the DSM-IV diagnostic criteria (experienced by 
about 20% of the sample) (Covey-Duchesne et al, 2016), we cannot confirm whether specific individual 
trajectories associated with self-rated depression caseness will also reliably predict clinical depression. 
Fourth, we cannot be certain that youth completing repeated SPHERE assessments were rating current 
symptoms only (as required by the SPHERE) or whether they rated current and past symptoms. Lastly, 
we did not compare the trajectories of SPHERE symptoms with any other clinical outcomes, such as 
evolution to DSM-5 mood or psychotic disorders, etc. However, further research is planned on this 
cohort, including any associations between symptom and illness trajectories with social and 
environmental predictors and dimensional approaches, such as structural equational or growth 
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modelling and network analysis. These approaches may also allow exploration of the centrality of 
specific symptoms to different outcomes according to sex (e.g. Cramer et al, 2016). 
 
In summary, the use of a screening tool that allows self-ratings of both psychological and somatic 
symptoms that are commonly associated with depression, but that overlap with other common mental 
health problems, provided valuable insights into the symptom trajectories as experienced in youth. The 
study offered evidence that supports the findings of the systematic review by Musliner et al (2016) 
regarding patterns or severity and stability of symptoms but extends the knowledge-base by 
demonstrating differences in self-rated sub-threshold symptom phenotypes in males and females. The 
next step involves assessment of these self-rated trajectories against structured clinical assessments and 
more sophisticated modelling of gender-specific pathways to major depression in a larger sample 
followed more intensively over a longer period. Using these approaches may provide a better 
understanding of the trajectories of self- or observer-rated depression, or fatigue or other syndromes, 
within a developmental framework and may help to further modify the intervention programmes being 
offered. 
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Figure 1: Schematic diagram representing the different trajectories between depression caseness (C) 
and non-caseness (N) for 600 individuals who completed three consecutive SPHERE assessments at 
12, 14 and 16 years (see text for details). 
 
 
 
Table 1: Cross-sectional SPHERE-12 caseness and adjusted odds in females vs males at ages 12, 14 and 
16. 
 MALES 
n (%) 
FEMALES 
n (%) 
ALL 
n (%) 
AOR 
95% CI 
AGE 12 †‡ 282 318 600  
DEPRESSION CASENESS 66 (23) 73 (24) 139 (24) 1.04 (0.71, 1.53) 
PSYCH 23 (8) 32 (8) 55 (8) 1.26 (0.72, 2.02) 
SOMA 46 (16) 59 (19) 105 (18) 1.16 (0.77, 1.79) 
NON-CASE 147 (52) 154 (48) 301 (50) 0.86 (0.63, 1.19) 
AGE 14 ‡ 355 395 750  
DEPRESSION CASENESS 84 (24) 121 (30) 205 (27) 1.43 (1.03, 1.97) 
PSYCH 15 (4) 44 (11) 59 (8) 2.85 (1.55, 5.20) 
SOMA 99 (28) 81 (21) 180 (24) 0.67 (0.48, 0.95) 
NON-CASE 157 (44) 149 (38) 306 (41) 0.76 (0.52, 1.02) 
AGE 16 † 337 377 714  
DEPRESSION CASENESS 88 (26) 125 (33) 213 (30) 1.41 (1.02, 1.94) 
PSYCH 16 (5) 35 (9) 51 (7) 2.05 (1.11, 3.78) 
SOMA 89 (26) 64 (17) 153 (22) 0.57 (0.39, 0.82) 
NON-CASE 144 (43) 153 (41) 297 (42) 0.92 (0.68, 1.23) 
Notes: n = number, % = Percentage rounded to nearest whole number. AOR = Adjusted Odds 
Ratio (reference = male); 95% CI = 95% confidence intervals. 
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SPHERE-12 ratings = DEPRESSION caseness (SOMA≥3 and PSYCH≥2); PSYCH (SOMA<3 
and PSYCH≥2); SOMA (SOMA≥3 and PSYCH<2). 
‡† Sample includes individuals with ratings at ages 12, 14 and 16; ‡ Sample includes individuals 
with ratings at ages 14 and 16; 
† Sample includes individuals with ratings at ages 12 and 16. Bolded numbers are statistically 
significant. 
 
Table 2: Longitudinal analysis of likelihood of self-rated DEPRESSION caseness at age 16 according to 
level of SPHERE-12 casesness at ages 12 or 14. 
 
 
DEPRESSION CASENESS AT AGE 16 
OR (95% CI) AOR (95% CI) 
AGE 12 (n=714)   
DEPRESSION CASENESS 1.33 (1.05, 1.68) 1.68 (1.22, 2.32) 
PSYCH 1.44 (1.00, 2.07) 1.57 (1.02, 2.04) 
SOMA 1.43 (0.91, 2.25) 0.97 (0.68, 1.39) 
AGE 14 (n=750)   
DEPRESSION CASENESS 1.26 (1.03, 1.97) 1.88 (1.32, 2.63) 
PSYCH 1.31 (1.01, 1.70) 1.58 (1.11, 2.25) 
SOMA 0.95 (0.78, 1.16) 0.72 (0.41, 1.24) 
Notes: OR = Odds Ratio (reference = males); AOR = Adjusted Odds 
Ratio (reference = males);  
95% CI = 95% confidence intervals. SPHERE-12 ratings = 
DEPRESSION caseness (SOMA≥3 and PSYCH≥2);  
PSYCH (SOMA<3 and PSYCH≥2); SOMA (SOMA≥3 and 
PSYCH<2).  
Bolded numbers are statistically significant. 
 
 
 
 
HIGHLIGHTS 
 Assessment of adolescent depression uses tools weighted towards psychological 
symptoms. 
 We employed a depression screening tool that also identified sub-threshold 
psychological and somatic phenotypes.  
 57% of youth met criteria for self-reported depression caseness at least once.  
 There were sex differences in rates of sub-threshold psychological and somatic 
phenotypes. 
 Illness trajectories were variable over time, and eight different patterns were 
identified. 
 
